Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response

OBJECTIVES: Assessment of the adaptive immune response against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is crucial for studying long‐term immunity and vaccine strategies. We quantified IFNγ‐secreting T cells reactive against the main viral SARS‐CoV‐2 antigens using a standardised...

Descripción completa

Detalles Bibliográficos
Autores principales: Demaret, Julie, Lefèvre, Guillaume, Vuotto, Fanny, Trauet, Jacques, Duhamel, Alain, Labreuche, Julien, Varlet, Pauline, Dendooven, Arnaud, Stabler, Sarah, Gachet, Benoit, Bauer, Jules, Prevost, Brigitte, Bocket, Laurence, Alidjinou, Enagnon Kazali, Lambert, Marc, Yelnik, Cécile, Meresse, Bertrand, Dubuquoy, Laurent, Launay, David, Dubucquoi, Sylvain, Montaigne, David, Woitrain, Eloise, Maggiotto, François, Bou Saleh, Mohamed, Top, Isabelle, Elsermans, Vincent, Jeanpierre, Emmanuelle, Dupont, Annabelle, Susen, Sophie, Brousseau, Thierry, Poissy, Julien, Faure, Karine, Labalette, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757425/
https://www.ncbi.nlm.nih.gov/pubmed/33376594
http://dx.doi.org/10.1002/cti2.1217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757425/
https://www.ncbi.nlm.nih.gov/pubmed/33376594
http://dx.doi.org/10.1002/cti2.1217

Ejemplares similares